An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
I just have two questions on the use of anticoagulants on dental patients.1 First, in the paragraph on managing risk it says:
Before undertaking any treatment, dentists must obtain a thorough medical history from the patient. This includes the name, dose and prescriber of all drugs.
Does the author really mean that the prescriber should be noted for each drug? I am wondering whether this is an error and perhaps was meant to be duration, or purpose? If not, for what reason should the prescriber be noted? This would be difficult information for many patients to provide accurately and difficult to substantiate for long-term therapy.
Second, there is no mention of the use of post-extraction tranexamic acid mouth rinse in this article. Despite strong support for its use after dental extractions in patients on warfarin, there are mixed opinions within the dental profession on the role of this mouthwash for patients on direct-acting oral anticoagulants.
Certainly, there is no evidence that it actually works and the absence of a proprietary product makes it difficult to support. However, many dental practitioners use it with the new oral anticoagulants just in case. A statement in the article on its role would have been helpful.
REFERENCE
1.Daly C.
Treating patients on new anticoagulant drugs. Aust Prescr
2016;39:205-7. 10.18773/austprescr.2016.085 [DOI] [PMC free article] [PubMed] [Google Scholar]
Christopher Daly, the author of the article, comments: It should be standard practice for dentists to record the name of the patient’s GP and any specialist physicians as they may need to be contacted to discuss the patient’s medical status or medicines. It also provides a medicolegal record in the patient’s notes. When listing the medicines, it is necessary to record the prescriber as it is not uncommon for patients to be prescribed drugs from both their GP and specialists. During a dental visit, it should be standard practice to review and update the patient’s medical status as well as prescription and over-the-counter medicines.
For patients on warfarin, randomised controlled trials have shown that tranexamic acid mouthwash prevents bleeding after dental extractions.1a–3 No such trials have been reported for the new anticoagulants. The dental management guideline for patients taking new anticoagulant drugs does not advise using tranexamic acid mouthwash as there is insufficient evidence to show any additional benefit over local measures (haemostatic plugs, suturing and compression).4
Whereas warfarin inhibits synthesis of coagulation factors II, VII, IX and X, the new anticoagulants directly inhibit one specific factor – either thrombin (dabigatran) or factor Xa (apixaban and rivaroxaban). Thus, the clotting cascade beyond factor X is irreversibly turned off while these drugs are in the circulation. In the absence of evidence-based data of efficacy and on the basis of the pharmacological effects of the new anticoagulants, tranexamic acid mouthwash is not recommended as a post-extraction measure.
REFERENCES
1a.Sindet-Pedersen S, Ramström G, Bernvil S, Blombäck M.
Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med
1989;320:840-3. 10.1056/NEJM198903303201305 [DOI] [PubMed] [Google Scholar]
2.Borea G, Montebugnoli L, Capuzzi P, Magelli C.
Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy. Oral Surg Oral Med Oral Pathol
1993;75:29-31. 10.1016/0030-4220(93)90401-O [DOI] [PubMed] [Google Scholar]
3.Ramström G, Sindet-Pedersen S, Hall G, Blombäck M, Alander U.
Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg
1993;51:1211-6. 10.1016/S0278-2391(10)80291-5 [DOI] [PubMed] [Google Scholar]
